Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
Fondazione IRCCS Istituto Nazionale dei Tumori · University of Milan · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
3,713
total citations
- FWCI
- 42.75
- Percentile
- 100%
- References
- 399
Citations per year
Authors
5- GMGiorgio MinottiCorresponding
Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, University of Chieti-Pescara
- PMPierantonio Menna
Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, University of Chieti-Pescara
- ESEmanuela Salvatorelli
University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Chieti-Pescara
- GCGaetano Cairo
University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Chieti-Pescara
- LGLuca Gianni
Fondazione IRCCS Istituto Nazionale dei Tumori, University of Chieti-Pescara, University of Milan
Topics & keywords
Topics
Keywords
- Cardiotoxicity
- Anthracycline
- Idarubicin
- Medicine
- Doxorubicin
- Pharmacology
- Epirubicin
- Heart failure
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.